UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
1126
DELISTED
New Relic, Inc.
NEWR
| $4.94M | ﹤0.01% |
87,540
+1,476
| +2% | +$83.5K |
|
|
FTCH
1127
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $4.87M | ﹤0.01% |
1,030,011
+4,761
| +0.5% | +$33.2K |
|
1128
Signet Jewelers
SIG
$3.76B
| $4.85M | ﹤0.01% |
71,337
+415
| +0.6% | +$26.4K |
|
1129
ICU Medical
ICUI
$4.61B
| $4.85M | ﹤0.01% |
30,792
-326
| -1% | -$49.6K |
|
|
CHCT
1130
Community Healthcare Trust
CHCT
$454M
| $4.85M | ﹤0.01% |
135,431
+35,938
| +36% | +$1.22M |
|
1131
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
| – | – |
0
| – | – |
|
|
CADE
1132
DELISTED
Cadence Bank
CADE
| $4.84M | ﹤0.01% |
196,289
-11,479
| -6% | -$308K |
|
1133
Qualys
QLYS
$6.35B
| $4.84M | ﹤0.01% |
43,083
+3,972
| +10% | +$496K |
|
1134
Zentalis Pharmaceuticals
ZNTL
$302M
| $4.83M | ﹤0.01% |
240,008
+14,112
| +6% | +$304K |
|
1135
Weibo
WB
$1.95B
| $4.82M | ﹤0.01% |
252,264
+20,992
| +9% | +$316K |
|
1136
Insperity
NSP
$2.01B
| $4.8M | ﹤0.01% |
42,240
| – | – |
|
1137
Empire State Realty Trust
ESRT
$836M
| $4.79M | ﹤0.01% |
710,110
+47,750
| +7% | +$336K |
|
|
DEN
1138
DELISTED
Denbury Inc.
DEN
| $4.75M | ﹤0.01% |
54,609
+516
| +1% | +$46.9K |
|
1139
Boyd Gaming
BYD
$6.06B
| $4.74M | ﹤0.01% |
86,961
-1,114
| -1% | -$62.7K |
|
1140
BOK Financial
BOKF
$8.74B
| $4.73M | ﹤0.01% |
45,586
+285
| +0.6% | +$28.9K |
|
1141
10x Genomics
TXG
$6.61B
| $4.68M | ﹤0.01% |
128,495
-1,018
| -0.8% | -$33.3K |
|
|
CSR
1142
Centerspace
CSR
$952M
| $4.67M | ﹤0.01% |
79,617
+15,198
| +24% | +$982K |
|
1143
Lufax Holding
LU
$1.3B
| $4.66M | ﹤0.01% |
600,919
+46,229
| +8% | +$352K |
|
|
TMHC
1144
DELISTED
Taylor Morrison
TMHC
| $4.66M | ﹤0.01% |
153,412
+13,554
| +10% | +$378K |
|
1145
Rambus
RMBS
$11B
| $4.66M | ﹤0.01% |
129,971
+13,799
| +12% | +$467K |
|
1146
SoFi Technologies
SOFI
$23.7B
| $4.65M | ﹤0.01% |
1,008,748
+69,119
| +7% | +$343K |
|
1147
CVB Financial
CVBF
$3.99B
| $4.64M | ﹤0.01% |
180,208
+12,577
| +8% | +$343K |
|
1148
GATX Corp
GATX
$6.27B
| $4.58M | ﹤0.01% |
43,083
+8,623
| +25% | +$898K |
|
1149
Grupo Cibest SA
CIB
$21.1B
| $4.58M | ﹤0.01% |
160,409
-1,600
| -1% | -$41.4K |
|
1150
Belden
BDC
$5.19B
| $4.57M | ﹤0.01% |
63,560
+1,108
| +2% | +$80.4K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.